David M. Compton

Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

Vincent M. Showalter, David M. Compton, BR Martin et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 572 citations

Medicine, Neuroscience, Pharmacology +14

Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

David M. Compton, Kenner C. Rice, Barbara Costa et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 464 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

P.Blaise Smith, David M. Compton, Sandra P. Welch et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 394 citations

Medicine, Neuroscience, Pharmacology +7

In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.

David M. Compton, Mario D. Aceto, John Lowe et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 360 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.

Patrick Little, David M. Compton, M R Johnson et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 292 citations

Medicine, Medicinal Chemistry, Pharmacology +7